Silje Nord from the Genome variation group, Department of Genetics at the Institute for Cancer Research has been awarded a prestigious career grant from Helse Sør-Øst for the proposal "Making sense of GWAS data". The grant amounts to NOK 2 million per year and runs for 4 years.
Published in major journals, first or last author from Oslo University Hospital.
Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial
Lancet, 385 (9978), 1653-61
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis
Gastroenterology, 148 (5), 924-927.e2
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
Hepatology, 61 (5), 1651-9